Evidence map›Paper›PMID 42761279›Full record

ArticleOpen forum infectious diseases2026

Contemporary Trends in Candidemia: Mortality, Species, and Antifungal Resistance Across Three Periods (2017-2025) in Houston, Texas.

Mary North Jones, Masayuki Nigo, María Alejandra Pérez, Stefano Casarin, Aarjav Sanghvi, Stephen L Jones, David B Corry, Cesar A Arias, Max W Adelman

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary North JonesDivision of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.ORCID https://orcid.org/0009-0000-4028-3402
Masayuki NigoDivision of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-4898-1808
María Alejandra PérezCenter for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-4901-824X
Stefano CasarinCenter for Precision Surgery, Houston Methodist Research Institute, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-7416-2366
Aarjav SanghviCenter for Health Data Science and Analytics, Houston Methodist Hospital, Houston, Texas, USA.ORCID https://orcid.org/0009-0006-8107-9735
Stephen L JonesCenter for Health Data Science and Analytics, Houston Methodist Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-1106-171X
David B CorryDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Cesar A AriasDivision of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-9054-9774
Max W AdelmanDivision of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-9277-6046

Funding

Pathogen and patient determinants of Candida gut colonization in critically ill patientsK23AI185174 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI Max Wiener Adelman · 2024 to 2026
$582k
NIAID NIH HHS K23 AI185174
6 · The paper itself

Abstract

Background: Methods: In a retrospective cohort study of patients with candidemia in Houston, TX, we compared clinical characteristics, species, and resistance between 3 periods (P1, 2017-2019; P2, 2020-2022; and P3, 2023-2025) and assessed contribution to mortality. We compared 30-day mortality in candidemia versus bacteremia. Results: Among 1275 patients with candidemia (1386 episodes), 30-day mortality increased from P1 to P2 (19.7% vs 31.9%, Conclusions: Increased post-candidemia mortality was associated in part with demographic changes and not with species or resistance changes. Factors underlying the persistent increase in post-candidemia mortality are unclear.

Indexed as

Antifungal resistanceCandidemiaC. aurisFungal infection

Identifiers

PMID42761279
PMCPMC13586760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.